AbbVie Challenges Fairness Of Upcoming Testosterone Trials
As the lawsuits against testosterone makers continue to mount, AndroGel manufacturer AbbVie is raising questions about whether the process of picking the bellwether cases is fair enough.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news